King's College London

King's main site

Research portal

Dr Maxine Patel

1 - 4 out of 4Page size: 50

Sort by: Start date

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 747 on Negative Symptoms in Subjects with Schizophrenia.
Amgen Inc.
Patel, M.
£117,843.00
21/09/2012 → 25/07/2013
Project: Research
Optimising Individualised prescribing with therapeutic drug Monitoring for Antipsychotics (OptIMA)
NIHR National Institute for Health Research
Patel, M., David, A., Kapur, S.
£950,314.36
1/03/2010 → 28/02/2015
Project: Research
The prevalence of depot antipsychotic and Clozapine prescribing from first presentation to 10 - year follow up in an ethically diverse epidemiologically - based sample of people with psychosis
Mental Health Research Network
Carveth, J., Dazzan, P., Fearon, P., Morgan, C., Patel, M.
£39,947.00
1/08/2008 → 31/07/2009
Project: Research
Review of patients attitudes to depot antipsychotic medication
Eli Lilly & Co Ltd
Patel, M.
£84,077.00
29/10/2007 → 31/10/2009
Project: Research

Export:Word PDF Excel - will at most contain 500 items

Search within the list

Refine results Clear filters

Type

Type

Research Grant Studentship (1)
Research Grant (1)
Research Grant Fellowship (1)
Clinical Trial CTIMP (non-commercially sponsored) (1)

Show more...Show fewer

Status

Show more...Show fewer

Funding Programme

Funding Programme

(4)

Show more...Show fewer

Funding Category

Funding Category

UK Government and Local, Health & Hospital Authorities, excl. NIHR (1)
NIHR (1)
Industry - UK (1)
Other Sources - UK (1)

Show more...Show fewer

Funding Body

Funding Body

Eli Lilly & Co Ltd (1)
NIHR National Institute for Health Research (1)
Amgen Inc. (1)
Mental Health Research Network (1)

Show more...Show fewer

King's College London - Homepage

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454